title: Which first-line treatment is superior in advanced colorectal cancer: XELOX or pviFOX?
authors: Cancer Research UK, Department of Medical Oncology, University of Glasgow, Garscube Estate, Glasgow, UK. j.cassidy@beatson.gla.ac.uk
authors: James
authors: J
authors: Cassidy